Copyright: ©Author(s) 2026.
World J Clin Pediatr. Dec 9, 2026; 15(4): 122059
Published online Dec 9, 2026. doi: 10.5409/wjcp.122059
Published online Dec 9, 2026. doi: 10.5409/wjcp.122059
Table 1 Summary of genes identified in Kawasaki disease through whole exome sequencing, whole genome sequencing, and targeted sequencing approaches
| Ref. | Cohort size | Sequencing approach | Genetic variants identified | rs IDs (reference SNP IDs) | Observed associations |
| Kim et al[23] | 6 family members including 2 siblings affected with KD (n = 6) | WGS | Rare: TLR6, MEF2A common: ARRDC4, SLK, TACSTD2 | rs5743809, rs35220466, rs12650224, rs6822503, rs12645200, rs5743826, rs6837101, rs373652230, rs1552673, rs10786779, rs6584583 and rs14008 | TLR6-NF-κB signalling pathway upregulation |
| Kanda et al[42] | Refractory KD (n = 1) | WGS | ORAI1, BLK | rs3741596 and rs2254546 | Calcineurin/NFAT signalling pathway upregulation |
| Shrestha et al[34] | KD (n = 472) | WGS | FANK1, MAP2K3, KCNJ12, FRG1DP, FRG1BP, DEFB115, CWH43, CCZ1B, MIR3683, FRG1JP, FLJ43315 | rs77740910, rs73368612, rs113336767, rs75317727, C20_29079715, C20_30491365, C4_49554582, C7_6981323, C9_63906587 | IVIG resistance |
| CA10 | rs74255119 | IVIG responsiveness | |||
| Shrestha et al[35] | KD (n = 504) | WGS | KLRC2, ZMAT4, NDUFA5, MICU2, PTPRD, TCAF2, WHAMM, LOC100127, ACTR3BP2, MYBPC3, FRG1DP | rs62154092, rs28730284, rs9643846, rs9643847, rs57504215, rs60545202, rs59556769, rs73677451, rs12676292, rs4332118, rs6988966, rs10276547, rs10280266, rs600075, rs5896385, rs1218424730, rs11259953, rs11259954, rs34163760, rs12585631, rs1052373, rs1424006606, rs1396081550, rs1258107032, rs1379390981, rs1424309393 | Disease susceptibility, severity, and CAAs involving immune dysregulation, mitochondrial dysfunction and vascular remodelling pathways |
| Kim et al[33] | KD (n = 200) | WES | FCRLA, PTGER4, IL17F, CARD11, SIGLEC10 | rs2275603, rs755244149, rs117796773, rs41493047, and rs201376644 | Disease susceptibility |
| IL31RA, FGFR4, FNDC1, MMP8, FOXN1 | rs148721785, rs201812753, rs374967242, rs61754773, and rs188424977 | Development of CAAs | |||
| Zhang et al[22] | KD (n = 93) | WES | RBP3 and MYH14 | RBP3: c.2650G>A, MYH14: c.566G>A, MYH14: c.1109C>T, MYH14: c.3917T>G, MYH14: c.4301G>A, MYH14: c.5026C>T, MYH14: c.5329 C>T, MYH14: c.5393 C>A, and MYH14: c.5476 C>T | Rare coding variants |
| Xu et al[40] | KD (n = 1272) | WES | USH2A, LMO7, CEMIP, EFCC1 | rs148135241, rs142687160, rs12441101, and rs142391828 | Sex-biased variants |
| Wang et al[44] | KD (n = 110) | WES | HLA-DRB1, IL6ST, IL17RC, VEGFB, ITPKC, CASP3, ORAI1, MYH11, SMAD9 | rs17882084, rs781455079, rs143781415, rs776229557, rs76358638, rs577739464, rs769061106, rs146388001, rs185661462, rs758895653, rs767136120, rs397514715 and rs200651392 | Disease susceptibility and development of CAAs |
| Nakamura et al[46] | KD + PFAPA (n = 3) | WES | CARD8 | rs140826611 | Inflammasome link (NLRP3 regulation) |
| Chen et al[21] | KD (n = 330) | Targeted gene panel | CD247, PPIE, FLT4, CUL1, LBP, IL2RA, MAP2K1, MAPK11 | rs840016, rs2463260, rs56401579, rs56193546, rs10271133, rs2007404, rs12358961, rs16949924, rs2232595, and rs742185 | IVIG resistance |
| ACVR2B, CD24 | rs77317995, rs6530599, rs6530600, rs1136210 | IVIG responsiveness | |||
| Amano et al[38] | KD (n = 82) | Targeted gene panel | IL-4R | rs563535954 | IVIG responsiveness |
| Song et al[39] | KD (n = 190) | Targeted gene panel | ITPR3, PIK3CD, PRKCZ | rs2229634, rs11121484, rs1141402, rs34108055 | Dysregulated innate immune signaling in KD |
- Citation: Kumar A, Thakur V, Dhaliwal M, Kaur T, Raj K, Kabeerdoss J, Rawat A, Pilania RK. Deciphering Kawasaki disease genetics through next-generation sequencing: A scoping review. World J Clin Pediatr 2026; 15(4): 122059
- URL: https://www.wjgnet.com/2219-2808/full/v15/i4/122059.htm
- DOI: https://dx.doi.org/10.5409/wjcp.122059